7Baggers
 Context Therapeutics Gains 11%, Insider Trades Reap Benefit  simplywall.st Fri, 03 Oct 2025 10:26:36 GMT
 published on: 2025-09-23 11:28:30  newser.com Tue, 23 Sep 2025 16:28:30 GMT
 Guggenheim Begins Coverage on Context Therapeutics (NASDAQ:CNTX)  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 context therapeutics (nasdaq:cntx) now covered by guggenheim  MarketBeat Mon, 22 Sep 2025 05:34:48 GMT
 published on: 2025-09-21 21:44:31  newser.com Mon, 22 Sep 2025 02:44:31 GMT
 published on: 2025-09-20 21:03:04  newser.com Sun, 21 Sep 2025 02:03:04 GMT
 published on: 2025-09-20 01:34:13  newser.com Sat, 20 Sep 2025 06:34:13 GMT
 context therapeutics inc. (nasdaq:cntx) short interest update  MarketBeat Wed, 17 Sep 2025 09:28:45 GMT
 published on: 2025-09-17 02:02:32  newser.com Wed, 17 Sep 2025 07:02:32 GMT
 Context Therapeutics initiated with a Buy at Guggenheim  TipRanks Wed, 17 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 09:03:19  newser.com Tue, 16 Sep 2025 14:03:46 GMT
 published on: 2025-09-16 16:44:30  خودرو بانک Tue, 16 Sep 2025 13:18:04 GMT
 context therapeutics inc. (nasdaq:cntx) short interest update  MarketBeat Mon, 15 Sep 2025 09:10:34 GMT
 published on: 2025-09-09 01:57:25  Newser Tue, 09 Sep 2025 06:57:25 GMT
 published on: 2025-09-08 14:53:40  Newser Mon, 08 Sep 2025 19:53:40 GMT
 published on: 2025-09-08 09:06:01  Newser Mon, 08 Sep 2025 14:06:01 GMT
 published on: 2025-09-08 00:10:24  Newser Mon, 08 Sep 2025 05:10:24 GMT

Context Therapeutics Inc.
(NASDAQ:CNTX) 

CNTX stock logo

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a selective potent antagonist of the progesterone receptor that is linked to resis...

Founded: 2015
CEO: Martin Lehr  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends